All Investor activism articles
-
BusinessInvestor kills planned Huntsman–Clariant merger
Merger of equals abandoned after major Clariant investor said the deal would destroy stakeholder value
-
Business$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members
-
-
Business
DuPont overcomes investor challenge
Shareholders decline to elect activist board nominees in a show of support for the current management’s strategy